2013
DOI: 10.3747/pdi.2012.00171
|View full text |Cite
|
Sign up to set email alerts
|

Purple Icodextrin: Turkish Delight?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2017
2017
2018
2018

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 9 publications
0
3
0
Order By: Relevance
“…90,91 After careful investigation, it turned out that this phenomenon was secondary to a chemical reaction between the iodine present in the disconnect cap and an icodextrin solution manufactured in Turkey which differed from that produced by other manufacturers by its greater fraction of large polymers. 92 No clinical significance was noted by the authors. Since 2011, this particular icodextrin has not been available.…”
Section: Purple Dialysatementioning
confidence: 73%
See 1 more Smart Citation
“…90,91 After careful investigation, it turned out that this phenomenon was secondary to a chemical reaction between the iodine present in the disconnect cap and an icodextrin solution manufactured in Turkey which differed from that produced by other manufacturers by its greater fraction of large polymers. 92 No clinical significance was noted by the authors. Since 2011, this particular icodextrin has not been available.…”
Section: Purple Dialysatementioning
confidence: 73%
“…Between 2001 and 2011, a transient purple discoloration was noted by several patients and clinicians in Europe of the very early drainage phase of a 7.5% icodextrin solution, a starch‐derived glucose polymer . After careful investigation, it turned out that this phenomenon was secondary to a chemical reaction between the iodine present in the disconnect cap and an icodextrin solution manufactured in Turkey which differed from that produced by other manufacturers by its greater fraction of large polymers . No clinical significance was noted by the authors.…”
Section: Purple Dialysatementioning
confidence: 95%
“…That icodextrin per se has no profibrotic properties (44) may explain the current safe use of icodextrin-containing dialysate, also in our cohort. Interestingly, unexpected differences in the specific composition of dialysate may also occur (45). Consequently, changes in dialysate composition, perhaps sometimes being transient and even remaining unnoticed, could play a role in altering the incidence of EPS.…”
Section: Discussionmentioning
confidence: 99%